Breaking through the mucus barrier
A capsule that tunnels through mucus in the GI tract could be used to orally administer large protein drugs such as insulin.
A capsule that tunnels through mucus in the GI tract could be used to orally administer large protein drugs such as insulin.
A new device, which doesn’t rely on immunosuppressing drugs, may assist efforts to develop an artificial pancreas to treat diabetes.
The findings of a large-scale screen could help researchers design nanoparticles that target specific types of cancer.
With particles that release their payloads at different times, one injection could provide multiple vaccine doses.
Foams that incorporate small amounts of the gas could be delivered to the GI tract to combat colitis and other conditions.
Institute Professor honored for groundbreaking work in nucleic acid delivery and nanoparticles.
Tested using a new brain tissue model, the particles may be able to deliver chemotherapy drugs for glioblastoma.
Mixing drugs into oil-based gels could offer relief for children and adults who have trouble swallowing pills.
MIT and Mass General Brigham researchers and physicians connect in person to bring AI into mainstream health care.
A new analysis offers guidance on the size of nanoparticles that could be most effective at stopping internal bleeding.
MIT biologists drilled down into how proteins recognize and bind to one another, informing drug treatments for cancer.
A pill that releases RNA in the stomach could offer a new way to administer vaccines, or to deliver therapies for gastrointestinal disease.
Sachin Bhagchandani wins NCI Predoctoral to Postdoctoral Fellow Transition (F99/K00) Award.
The new pill can inject large quantities of monoclonal antibodies and other drugs into the lining of the stomach after being swallowed.
The results may help engineers develop a way to inject drugs without needles.